November 14th, 2025: Three New Jersey Cases Added to Expanding GLP-1 Drug MDL A federal judicial panel has transferred three additional lawsuits from New Jersey into the growing multidistrict litigation involving claims that Eli Lilly and Novo Nordisk minimized the safety risks associated with GLP-1 medications, including Ozempic, Wegovy, Mounjaro, and Trulicity
Additionally, some patients may start with injectable semaglutide and later transition to the sublingual form
The FAQ states oral semaglutide can be as effective as injectables, but the study cited is based on a 50 mg FDA-approved formulation with SNAC absorption technology, not compounded oral drops or tablets
That last tip is a lesson that Melissa Milender has learned firsthand
A citrusy-spicy opening settles into a deep woody-amber baseperfect for evenings and statement moments
Minimum Downtime: Treatments are minimally invasive, with little or no downtime or recovery period